dextroamphetamine has been researched along with MPTP Neurotoxicity Syndrome in 4 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ourednik, J | 1 |
Ourednik, V | 1 |
Lynch, WP | 1 |
Schachner, M | 1 |
Snyder, EY | 1 |
Steindler, DA | 1 |
Schroeder, U | 1 |
Kreutz, MR | 1 |
Schroeder, H | 1 |
Sabel, BA | 1 |
Gerhardt, GA | 1 |
Cass, WA | 1 |
Huettl, P | 1 |
Brock, S | 1 |
Zhang, Z | 1 |
Gash, DM | 1 |
4 other studies available for dextroamphetamine and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Cell Count; Cell Survival; Dextroamphe | 2002 |
Neural stem cells, scaffolds, and chaperones.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biocompatible Materials; Cell Survival; Dextr | 2002 |
Amphetamine induces hypermotility in MPTP-lesioned mice.
Topics: Animals; Apomorphine; Cell Membrane; Corpus Striatum; Dextroamphetamine; Dopamine Agents; Dopamine A | 1997 |
GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Basal Metabolism; Dextroamphetamine; Dopamine; Dopamine Age | 1999 |